Education
About Us
Working with TipRanks
Follow Us
Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE:DNA
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 170.16M | $ 227.04M | $ 251.46M | $ 477.71M | $ 313.84M |
| Gross Profit | $ 138.63M | $ 188.49M | $ 197.45M | $ 273.49M | $ 184.15M |
| Operating Income | $ -315.28M | $ -559.76M | $ -864.41M | $ -2.21B | $ -1.83B |
| EBITDA | $ -254.61M | $ -484.39M | $ -821.29M | $ -2.06B | $ -1.81B |
| Net Income | $ -312.76M | $ -547.03M | $ -892.87M | $ -2.10B | $ -1.83B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 422.62M | $ 561.57M | $ 944.07M | $ 1.32B | $ 1.55B |
| Total Assets | $ 1.12B | $ 1.38B | $ 1.67B | $ 2.54B | $ 2.07B |
| Total Debt | $ 417.08M | $ 467.73M | $ 239.31M | $ 442.59M | $ 23.03M |
| Net Debt | $ 249.88M | $ -93.84M | $ -704.76M | $ -873.20M | $ -1.53B |
| Total Liabilities | $ 611.11M | $ 661.39M | $ 568.19M | $ 803.04M | $ 503.61M |
| Stockholders' Equity | $ 508.59M | $ 716.06M | $ 1.10B | $ 1.74B | $ 1.51B |
| Cash Flow | |||||
| Free Cash Flow | $ -178.72M | $ -382.13M | $ -336.30M | $ -304.47M | $ -310.34M |
| Operating Cash Flow | $ -171.06M | $ -319.58M | $ -295.50M | $ -252.20M | $ -253.82M |
| Investing Cash Flow | $ -240.29M | $ -62.24M | $ -80.69M | $ -67.39M | $ -73.26M |
| Financing Cash Flow | $ 17.77M | $ -1.74M | $ -3.22M | $ 95.34M | $ 1.53B |